Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 70, Number 21, May 20, 2008
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chahin, N.
Right arrow Articles by Sorenson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chahin, N.
Right arrow Articles by Sorenson, E.
Related Collections
Right arrow Prognosis
Right arrow Anterior nerve cell disease
Right arrow Natural history studies (prognosis)
Right arrow Trinucleotide repeat diseases
NEUROLOGY 2008;70:1967-1971
© 2008 American Academy of Neurology

Natural history of spinal-bulbar muscular atrophy

Nizar Chahin, MD, Christopher Klein, MD, Jayawant Mandrekar, PhD and Eric Sorenson, MD

From the Departments of Neurology (N.C., C.K., E.S.) and Biostatistics (J.M.), Mayo Clinic, Rochester, MN.

Address correspondence and reprint requests to Dr. Eric J. Sorenson, Department of Neurology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905 sorenson.eric{at}mayo.edu

Background: Although spinal-bulbar muscular atrophy (SBMA) is generally believed to be associated with better survival and function compared to other motor neuron diseases, no systematic study of long-term functional status or survival has been reported.

Methods: We report the results a retrospective review of 39 patients with genetically confirmed diagnosis and compared their survival to normal, population-based, age- and gender-matched controls. We assessed the functional status of 25 of the 33 survivors by completing the revised ALS Functional Rating Scale (ALSFRS-r) by telephone.

Results: The subjects with SBMA had a 10-year survival of 82% compared to 95% among the age-matched controls (p = 0.053). The mean ALSFRS-r score for the survivors was 37 (range 27–43). The ALSFRS-r subscores indicated mild deficits in all areas in most, with the greatest limitation being the use of stairs. While all reported bulbar symptoms, none had disabling deficits. None of the subjects required a percutaneous endoscopic gastrostomy tube and one subject used noninvasive positive pressure ventilation.

Conclusions: The long-term survival of subjects with spinal-bulbar muscular atrophy is minimally reduced from their age-matched controls. The long-term functional assessments demonstrate mild neurologic impairment in most without devastating bulbar or respiratory dysfunction and good ambulatory function years after diagnosis.

Abbreviations: ALS = amyotrophic lateral sclerosis; ALSFRS-r = revised ALS functional rating scale; NIPPV = noninvasive positive pressure ventilation; SBMA = spinal-bulbar muscular atrophy.

Disclosure: The authors report no disclosures.

Received September 14, 2007. Accepted in final form February 15, 2008.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.